Oxford Biomedica plc
OXB.L$1.10B
Small CapLSEGene Therapy🇺🇸North America900 employees
Drugs in Pipeline
4
Phase 3 Programs
1
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
OXB.L News
Catalyst Timeline
0 upcoming, 0 past
No catalysts found.
Drug Pipeline
Trovax
Clear Cell Renal Carcinoma
ProSavin
Parkinson's Disease
Interleukin-2
Carcinoma, Renal Cell
IL-2
Carcinoma, Renal Cell
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Trovax | Phase 3 | Clear Cell Renal Carcinoma | - | - |
ProSavin | Phase 2 | Parkinson's Disease | - | - |
Interleukin-2 | Phase 2 | Carcinoma, Renal Cell | - | - |
IL-2 | Phase 2 | Carcinoma, Renal Cell | - | - |
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply